Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Gregor Hron"'
Publikováno v:
Haematologica, Vol 92, Iss 9 (2007)
Low plasma vitamin B6, measured as pyridoxal-5’-phosphate (PLP), is associated with an increased risk of first venous thromboembolism (VTE). In a prospective cohort of 757 patients with first VTE we investigated the association of PLP levels with r
Externí odkaz:
https://doaj.org/article/847f6be3da50424f8b896f45db178d44
Autor:
Florian Lang, Daniela Eißler, Martin Schaller, Gregor Hron, Eva Geuss, Dominik Rath, Christoph Kleinschnitz, Tobias Geisler, Elke Schaeffeler, Sascha Geue, Stefan Winter, Matthias Schwab, Oliver Borst, Andreas Greinacher, Meinrad Gawaz, Patrick Münzer, Monika Meinert, Britta Walker-Allgaier
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 36:1507-1516
Objective— Activation of platelets by subendothelial collagen results in an increase of cytosolic Ca 2+ concentration ([Ca 2+ ] i ) and is followed by platelet activation and thrombus formation that may lead to vascular occlusion. The present study
Autor:
Sylvia Stracke, Gregor Hron
Publikováno v:
Dialyse aktuell. 19:86-95
Orale Antikoagulanzien werden zur Verhinderung thromboembolischer Ereignisse eingesetzt. Fur Nierenpatienten ist die haufigste Indikation fur eine dauerhafte Antikoagulation das Vorhofflimmern (VHF). Bisher wurden diese Patienten zumeist mit oralen A
Autor:
Karina Althaus, Folke Knutson, Andreas Greinacher, Christoph Busemann, Gregor Hron, Norbert Lubenow, Thomas Thiele, Sigrun Friesecke
Publikováno v:
Upsala Journal of Medical Sciences
Thrombocytopenia can cause diagnostic challenges in patients who have received heparin. Heparin-induced thrombocytopenia (HIT) is often considered in the differential diagnosis, and a positive screening can be mistaken as confirmation of the disorder
Autor:
Gregor Hron, Gottfried Novacek, Julia Palkovits, Pavol Papay, Paul A. Kyrle, Peter Quehenberger, Harald Vogelsang, Wolf Osterode, Marietta Kollars, A. Weltermann, Walter Reinisch
Publikováno v:
Journal of Crohn's and Colitis. 7:222-229
Background Circulating procoagulant microparticles (MPs) are thought to be involved in the pathogenesis of venous thromboembolism in patients with inflammatory bowel disease (IBD). However, the exposure of tissue factor, the primary initiator of coag
Autor:
A. Rogolino, Karina Althaus, Rosanna Abbate, Andreas Greinacher, Simon J. Davidson, Tamam Bakchoul, Ulrike Strobel, Gregor Hron
Publikováno v:
Thrombosis Research. 131:e85-e90
Background Heparin-induced thrombocytopenia (HIT) is caused by platelet-activating antibodies that recognize platelet factor 4/heparin (PF4/hep) complexes. The in vitro demonstration of PF4/hep antibodies using functional and immunological methods is
Autor:
Andreas Greinacher, Henry W. S. Schroeder, A. Sümnig, C. Müller, Karina Althaus, Gregor Hron, Thomas Thiele
Publikováno v:
Journal of Thrombosis and Haemostasis. 10:968-971
Autor:
Andreas Greinacher, Gregor Hron
Publikováno v:
Clinical Investigation. 1:1301-1314
Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug effect caused by platelet-activating antibodies to a complex of platelet factor 4 and heparin. Increasing evidence from clinical and laboratory studies suggests that HIT is ove
Autor:
Gregor Hron, Sarah Kellner, Andreas Greinacher, Theodore E. Warkentin, A. Wessel, Kathleen Selleng, Kathrin Zimmermann, Matthias Nauck, Christina Wasner, Thomas Thiele
Publikováno v:
Transfusion. 52:529-536
BACKGROUND: Rapid transfusion of fresh-frozen plasma (FFP) is desired for treating coagulopathies, but thawing and issuing of FFP takes more than 40 minutes. Liquid storage of plasma is a potential solution but uncertainties exist regarding clotting
Autor:
Ansgar Weltermann, Marietta Kollars, Verena Gartner, Barbara Lubsczyk, Paul A. Kyrle, Gregor Hron
Publikováno v:
European Journal of Clinical Investigation. 40:477-482
Eur J Clin Invest 2010; 40 (6): 477–482 Abstract Background Microparticles (MPs) have procoagulant properties as shown in vitro and in animal models. Their role in haemostatic system activation at the site of a vascular injury in vivo in humans has